BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8548778)

  • 1. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer.
    Kawajiri K; Eguchi H; Nakachi K; Sekiya T; Yamamoto M
    Cancer Res; 1996 Jan; 56(1):72-6. PubMed ID: 8548778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
    Goto I; Yoneda S; Yamamoto M; Kawajiri K
    Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
    Nakachi K; Imai K; Hayashi S; Kawajiri K
    Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polymorphism at p53, CYP1A1 and GSTM1 loci on p53 mutation and association of p53 mutation with prognosis in lung cancer.
    Wang YC; Chen CY; Wang HJ; Chen SK; Chang YY; Lin P
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):402-10. PubMed ID: 10418172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
    Xue K; Xu L; Chen S; Ma G; Wu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
    Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
    Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
    Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
    Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
    Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
    Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
    Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.